<VariationArchive RecordType="classified" VariationID="16010" VariationName="NM_002087.4(GRN):c.93_96dup (p.Asp33fs)" VariationType="Duplication" Accession="VCV000016010" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-01-15" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31049" VariationID="16010">
      <GeneList>
        <Gene Symbol="GRN" FullName="granulin precursor" GeneID="2896" HGNC_ID="HGNC:4601" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44345302" stop="44353106" display_start="44345302" display_stop="44353106" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42422490" stop="42430469" display_start="42422490" display_stop="42430469" Strand="+" />
          </Location>
          <OMIM>138945</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002087.4(GRN):c.93_96dup (p.Asp33fs)</Name>
      <CanonicalSPDI>NC_000017.11:44349253:CTGCCTG:CTGCCTGCCTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44349253" stop="44349254" display_start="44349253" display_stop="44349254" variantLength="4" positionVCF="44349253" referenceAlleleVCF="G" alternateAlleleVCF="GCTGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42426621" stop="42426622" display_start="42426621" display_stop="42426622" variantLength="4" positionVCF="42426621" referenceAlleleVCF="G" alternateAlleleVCF="GCTGC" />
      </Location>
      <ProteinChange>D33fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_661" sequenceAccession="LRG_661">
            <Expression>LRG_661:g.9135_9138dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42426625_42426628dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42426625_42426628dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44349257_44349260dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44349257_44349260dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007886.1" sequenceAccession="NG_007886" sequenceVersion="1" change="g.9135_9138dup">
            <Expression>NG_007886.1:g.9135_9138dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002087.4" sequenceAccession="NM_002087" sequenceVersion="4" change="c.93_96dup" MANESelect="true">
            <Expression>NM_002087.4:c.93_96dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002078.1" sequenceAccession="NP_002078" sequenceVersion="1" change="p.Asp33fs">
            <Expression>NP_002078.1:p.Asp33fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA257407" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="138945.0005" DB="OMIM" />
        <XRef Type="rs" ID="606231220" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002087.4(GRN):c.93_96dup (p.Asp33fs) AND GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" Accession="RCV000017383" Version="29">
        <ClassifiedConditionList TraitSetID="5202">
          <ClassifiedCondition DB="MedGen" ID="C1843792">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2008-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16862116</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18413474</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16401619</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5202" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5167" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ElementValue>
                <XRef ID="MONDO:0011842" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Frontotemporal dementia, ubiquitin-positive</ElementValue>
                <XRef ID="Frontotemporal+Dementia%2C+Ubiquitin-Positive/2945" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRN-Related Frontotemporal Dementia</ElementValue>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dementia, hereditary dysphasic disinhibition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0017" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FTLD-TDP, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FTDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTLDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HDDD</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530102" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of GRN frontotemporal dementia (GRN-FTD) includes the behavioral variant (bvFTD), primary progressive aphasia (PPA; further subcategorized as progressive nonfluent aphasia [PNFA] and semantic dementia [SD]), and movement disorders with extrapyramidal features such as parkinsonism and corticobasal syndrome (CBS). A broad range of clinical features both within and between families is observed. The age of onset ranges from 35 to 87 years. Behavioral disturbances are the most common early feature, followed by progressive aphasia. Impairment in executive function manifests as loss of judgment and insight. In early stages, PPA often manifests as deficits in naming, word finding, or word comprehension. In late stages, affected individuals often become mute and lose their ability to communicate. Early findings of parkinsonism include rigidity, bradykinesia or akinesia (slowing or absence of movements), limb dystonia, apraxia (loss of ability to carry out learned purposeful movements), and disequilibrium. Late motor findings may include myoclonus, dysarthria, and dysphagia. Most affected individuals eventually lose the ability to walk. Disease duration is three to 12 years.</Attribute>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301545</ID>
                <ID Source="BookShelf">NBK1371</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="100070" DB="Orphanet" />
              <XRef ID="282" DB="Orphanet" />
              <XRef ID="C1843792" DB="MedGen" />
              <XRef ID="MONDO:0011842" DB="MONDO" />
              <XRef Type="MIM" ID="607485" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37655" SubmissionDate="2016-08-12" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="138945.0005_FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS" title="GRN, 4-BP INS, NT90_FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS" />
        <ClinVarAccession Accession="SCV000037655" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a large Canadian family with 17 affected individuals segregating autosomal dominant frontotemporal dementia (607485), originally reported by Mackenzie et al. (2006), Baker et al. (2006) identified a 4-bp insertion of CTGC between coding nucleotides 90 and 91 (90insCTGC) of the GRN gene, resulting in a frameshift and premature termination in progranulin (Cys31LeufsTer34). The mean age of onset of dementia in this family was 58 years of age.</Attribute>
              <Citation>
                <ID Source="PubMed">16401619</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">16862116</ID>
              </Citation>
              <XRef DB="OMIM" ID="607485" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Rohrer et al. (2008) reported a large British kindred with FTLDU associated with the 90insCTGC mutation. The average age at disease onset was 57.8 years. All patients had clinical and radiographic features of frontotemporal lobar degeneration with behavioral changes and language deficits. Nonfluent aphasia was present in 2 patients, and 3 became mute several years into the illness. Most also had features suggestive of parietal lobe involvement, including dyscalculia, visuoperceptual/visuospatial dysfunction, and limb apraxia. Brain imaging showed extension of the atrophy to the parietal lobe. Haplotype analysis indicated common ancestry to the family reported by Mackenzie et al. (2006).</Attribute>
              <Citation>
                <ID Source="PubMed">18413474</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">16401619</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <Name>GRN, 4-BP INS, NT90</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, NT90</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="138945.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37655" TraitType="Disease" MappingType="Name" MappingValue="FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS" MappingRef="Preferred">
        <MedGen CUI="C1843792" Name="GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

